Positives:
- some positive press of late (no impact from CBEC)
- 2 brokers upgraded their ratings
- we are getting closer to AGM
- Healthy inventory levels at Jun18 and shelves still clearing fast (demand must be through the roof)
Negatives:
- Lots of directors selling shares including CEO cleaning her slate
- 20% drop in SP since CEO sold her shares
- 1 broker downgraded their rating
- A2M is afraid to update the market with Q1 sales and FY19 outlook
- Shorters are growing to 3.9% of issued capital (enticing investors with intraday increases followed by strong selling)
- No Fonterra update
Make your own mind up, but at $9.61 this is heavily undervalued IMO. It could easily hit $16 at year end if management achieve a 40% increase in sales.
My price targets are below based on various NPAT projections:
$200m - $8
$220m - $10
$240m - $12
$260m - $14
Positives: - some positive press of late (no impact from CBEC) -...
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.61 |
Change
-0.020(0.36%) |
Mkt cap ! $4.061B | |||
| Open | High | Low | Value | Volume |
| $5.69 | $5.74 | $5.60 | $10.03M | 1.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4199 | $5.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.64 | 2719 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| A2M (ASX) Chart |